Why India’s drug regulator has suspended licence for ‘Pres Vu’ eye drop that would ‘replace reading glasses’

The Drugs Controller General of India (DCGI) has suspended approval for PresVu, the eye drop that stirred excitement with its claim to replace reading glasses. The drug regulator revoked the marketing and manufacturing licences granted to drug maker Entod Pharmaceuticals citing ‘unauthorised promotion’ and concerns over the ‘unsafe use’ of the eye drops by patients


Discover more from The Doon Mozaic

Subscribe to get the latest posts sent to your email.

Leave a Reply

Your email address will not be published. Required fields are marked *

Discover more from The Doon Mozaic

Subscribe now to keep reading and get access to the full archive.

Continue reading